Patent details

EP1235573 Title: COMBINATION OF RILUZOLE AND GABAPENTIN AND USE THEREOF FOR THE TREATMENT OF MOTOR NEURON DISORDERS

Basic Information

Publication number:
EP1235573
PCT Application Number:
PCT/FR/00/03272
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009853151
PCT Publication Number:
WO/01/03783
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
COMBINATION OF RILUZOLE AND GABAPENTIN AND USE THEREOF FOR THE TREATMENT OF MOTOR NEURON DISORDERS
French Title of Invention:
ASSOCIATION DE RILUZOLE ET DE GABAPENTINE ET SON UTILISATION COMME MEDICAMENT DANS LE TRAITEMENT DES MALADIES MOTONEURONALES
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG WELCHE RILUZOL UND GABAPENTIN ENTHÄLT ZUR BEHANDUNG VON MOTONEURONALEN KRANKHEITEN
SPC Number:

Dates

Filing date:
24/11/2000
Grant date:
23/07/2003
EP Publication Date:
23/07/2003
PCT Publication Date:
31/05/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/09/2002
EP B1 Publication Date:
23/07/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/11/2013
Expiration date:
24/11/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/11/2000
 
 

Name:
Aventis Pharma S.A.
Address:
20, avenue Raymond Aron, 92160 Antony, France (FR)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
23/07/2003
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HENDERSON Christopher
Address:
France (FR)

2

Name:
BOHME Andrees
Address:
France (FR)

Priority

Priority Number:
9914765
Priority Date:
24/11/1999
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 31/425;
Filing date Document type Number of pages